ClinicalTrials.Veeva

Menu

Abdominal Aortic Aneurysm Screening Before Coronary Artery Bypass Surgery

B

Başakşehir Çam & Sakura City Hospital

Status

Enrolling

Conditions

Coronary Artery Disease
Abdominal Aortic Aneurysm

Treatments

Diagnostic Test: Abdominal aortic Duplex ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT05449509
KAEK/2022.02.43

Details and patient eligibility

About

Coronary artery disease (CAD) and abdominal aortic aneurysm (AAA) are two separate entities with common risk factors such as hypertension, advanced age, male sex. Atherosclerosis plays an important role in the etiology of both diseases. It has been reported that AAA is more prevalent in patients undergoing coronary artery bypass grafting (CABG). Despite all the evidence, current guidelines do not recommend routine screening for AAA before CABG. Syntax score shows anatomical significance of CAD and is associated with the degree of atherosclerotic load. The investigators aim to investigate if there were any differences regarding AAA prevalence in high-SYNTAX patients versus intermediate/low-SYNTAX patients.

Enrollment

170 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing coronary artery bypass graft surgery
  • Age >18 years

Exclusion criteria

  • Age <18 years
  • Pregnancy
  • Breastfeeding
  • Emergency surgery

Trial design

170 participants in 2 patient groups

High-SYNTAX score patients
Treatment:
Diagnostic Test: Abdominal aortic Duplex ultrasound
Intermediate/low-SYNTAX score patients
Treatment:
Diagnostic Test: Abdominal aortic Duplex ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Kamile Ozeren-Topcu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems